Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
An analysis of Medicare patient procedural data by Dr. Charles .M. Intenzo, a nuclear physician at Thomas Jefferson University in Philadelphia found that radiology’s share of procedures involving the administration of radioiodine dropped 7% from 1996 to 2007. At the same time, the number of procedures administered by endocrinologists jumped by nearly one-third (32%).
The total number of such procedures covered by Medicare Part B remained stable over the 10-year period. Medicare covered 13,273 procedures requiring radioiodine in 1996. The total in 2007 was 13,004.
Endocrinology practice revolves around a limited number of applications, so practitioners are naturally attracted to these procedures as a new source of income. Regulatory barriers to their involvement have fallen as the Department of Energy has watered down the minimum training requirements for isotope handling and administration, Intenzo said.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.